Final answer:
The statement is true; legislation designed to protect the public from dishonest or incompetent practitioners is regulatory in nature. Regulatory policies, like those enforced by the FDA, aim to safeguard public interests, though they may impose costs on businesses and delay product availability.
Step-by-step explanation:
True, if the purpose of the legislation is to protect the public against dishonest or incompetent practitioners, it is considered regulatory. Regulatory policies impose obligations on individuals, businesses, or other entities, with the goal of safeguarding the public interest.
The losers in these situations are often those companies facing the concentrated costs of regulatory compliance, including the expenses of lengthy and expensive testing procedures, altering business practices to meet new standards, or refraining from certain profitable activities.